MEU
Asset Logo

Marmota Limited

🇦🇺 ASX

⚡️ ENERGY

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

+ 5.37%
Annual Growth

5 years average annual growth

💵

$ 500
Minimum Order

Due to regulatory requirements

🌏

5
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Marmota Ltd. engages in exploring mineral activities. The company is headquartered in Adelaide, South Australia. The company went IPO on 2007-11-21. The firm is focused on gold, copper and uranium. The firm's projects include Gawler Craton, Copper Coast, Yorke Peninsula and Junction Dam. The Company’s copper project is based at the Melton project on the Yorke Peninsula. The firm's uranium project is at Junction Dam adjacent to the Honeymoon mine. The Gawler Craton gold project comprises around 6,000 square kilometers in the Woomera Prohibited Area. The company has been active on the Champion Prospect in the West Melton tenement (100% owned), on the Copper Coast of the Yorke Peninsula. Junction Dam is the Company’s flagship uranium project, located 50 kilometers (km) west of Broken Hill.

📈 Performance

Price History

+477.78%

1M

1Y

10Y

Graph

Table

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$0.05

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in MEU

5

📊 Total Capital Earnings

$-887.627

🔃 Average investment frequency

31 weeks

💵 Average investment amount

$2,592

Last time a customer invested in MEU

10 hours
MEU investor breakdown
💵 Income of investors

More than 200k

150k - 200k

20%

100k - 150k

40%

50k - 100k

Less than 50k

40%
👶 Age of investors

18 - 25

20%

26 - 34

40%

35 - 90

40%
🙋 Legal gender of investors

Female

40%

Male

60%

Pearlers who invest in MEU also invest in...

Vanguard Australian Shares Index ETF

VAS

VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

🙌 Performance (5Yr p.a)

3.43%

📊 Share price

$102.17 AUD

🧱 MATERIALS

⛳️ DIVERSIFIED

💸 FINANCIALS

🇦🇺 AUSTRALIA

Find Out More

VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.

🙌 Performance (5Yr p.a)

3.50%

📊 Share price

$69.12 AUD

⛳️ DIVERSIFIED

🌏 GLOBAL

Hazer Group Ltd. engages in the research and development of novel graphite, and hydrogen production technology. The company is headquartered in Perth, Western Australia. The company went IPO on 2015-12-02. The principal activity of the Company is the research and development of hydrogen and graphitic carbon production technology. The Company’s advanced technology enables the production of clean and economically competitive hydrogen and graphite, using a natural gas (or biogas) feedstock and iron-ore as the process catalyst. The firm has intellectual property rights to a technology (the Hazer Process), which enables the production of hydrogen gas from the thermo-catalytic decomposition of methane (natural gas) with low carbon dioxide emissions and the co-production of a high-purity graphite product. The firm's markets include industrial hydrogen, hydrogen mobility and synthetic graphite. The company has facilities, including a research and development lab and a fluid bed reactor pilot plant.

🙌 Performance (5Yr p.a)

-5.60%

📊 Share price

$0.36 AUD

🧪 CHEMICALS

VTS.AX was created on 2009-05-12 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard U.S. Total Market Shares Index ETF seeks to track the performance of the CRSP US Total Market Index, providing investors with exposure to a broadly diversified collection of securities that, in the aggregate, approximates the full index in terms of key characteristics.

🙌 Performance (5Yr p.a)

17.12%

📊 Share price

$464.74 AUD

📈 HIGH PRICE GROWTH

⛳️ DIVERSIFIED

🇺🇸 UNITED STATES

🤖 TECHNOLOGY

Archer Materials Ltd. is a materials technology company, which engages in the developing advanced semiconductor devices and processor chips related to quantum computing and medical diagnostics in Australia. The company is headquartered in Adelaide, South Australia. The company went IPO on 2007-08-14. The company is engaged in developing advanced semiconductor devices, including chips relevant to quantum computing and medical diagnostics. Its principal activities include technology development, including its quantum computing qubit processor chip (12CQ chip) and lab-on-a-chip biochip technology and utilizing semiconductor technology development infrastructure and facilities, research, and development to support research activities. The company focuses on advancing quantum computing and miniaturizing medical labs onto a chip. The company designs and integrates materials for operating qubits in quantum technologies and building graphene transistors for enhanced biosensing. Its development spans qubit processors for practical quantum computing technology, and lab-on-a-chip biosensors for integrated bioelectronics. The company develops its biochip for digitizing biologically relevant signals like those from viruses.

🙌 Performance (5Yr p.a)

18.33%

📊 Share price

$0.34 AUD

🤖 TECHNOLOGY

📈 HIGH PRICE GROWTH

Want more shares? Try these...

Compare
Add to watchlist